Roche Diabetes Care and Hospital de Granollers have signed a shared-risk agreement to provide patients with type-1 diabetes the latest technology for measuring glucose levels (Eversense XL).

The contract was facilitated by HiTT, a consultancy that specialises in transferring innovation to patients and a CataloniaBio & HealthTech member.

"Shared-risk agreements are being seen as solutions for getting technology to patients in which everyone wins: patients, healthcare providers and innovation developers," explains Oriol Solà-Morales, CEO of HiTT.

Photo: Lisa Huse, manager Roche Diabetes Spain; Dr Rafael Lledó, general manager of Hospital de Granollers, and Oriol Solà-Morales.